TRPV1 and Sepsis: While Szabó et al [47] and Keeble et al [48] have shown that TRPV1 activation aggravates inflammation in arthritis models, the use of TRPV1 agonists in models of AKI, cardiac ischemia and sepsis was associated with a diminished inflammatory response [23], [24], [49].